Form 8-K - Current report:
SEC Accession No. 0001493152-24-043658
Filing Date
2024-11-05
Accepted
2024-11-05 16:05:22
Documents
16
Period of Report
2024-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53964
2 ex10-1.htm EX-10.1 20533
3 ex10-2.htm EX-10.2 37801
4 ex10-3.htm EX-10.3 49534
  Complete submission text file 0001493152-24-043658.txt   357068

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE orgs-20241031.xsd EX-101.SCH 3018
6 XBRL LABEL FILE orgs-20241031_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE orgs-20241031_pre.xml EX-101.PRE 24167
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3427
Mailing Address 20271 GOLDENROD LANE GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE GERMANTOWN MD 20876 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

EIN.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38416 | Film No.: 241427419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)